PMID- 19216684 OWN - NLM STAT- MEDLINE DCOM- 20090729 LR - 20221207 IS - 1520-9156 (Print) IS - 1557-8593 (Electronic) IS - 1520-9156 (Linking) VI - 11 IP - 3 DP - 2009 Mar TI - Continuous glucose monitoring in non-insulin-using individuals with type 2 diabetes: acceptability, feasibility, and teaching opportunities. PG - 151-8 LID - 10.1089/dia.2008.0053 [doi] AB - BACKGROUND: Continuous glucose monitoring (CGM) has the potential to provide useful data for behavioral interventions targeting non-insulin-using, sedentary individuals with type 2 diabetes mellitus (T2DM). The aims of this study were to describe CGM in terms of (1) feasibility and acceptability and (2) dietary- and exercise-teaching events. METHODS: Cross-sectional data were analyzed from 27 non-insulin-using adults with T2DM who wore CGM for 72 h as part of a larger study on using CGM for exercise counseling in this population. Feasibility data included accuracy of entering daily self-monitored blood glucose (SMBG) readings and events (e.g., meals, exercise), sensor failures, alarms, optimal accuracy of glucose data, and download failures. Acceptability data included CGM satisfaction and wearing difficulties. Dietary- and exercise-teaching events were identified from CGM and activity monitor data. RESULTS: CGM graphs showed 141 dietary- and 71 exercise-teaching events. About half the participants (52%) reported difficulty remembering to enter events into CGM monitors, but most (82%) kept an accurate paper log of events. Insufficient SMBG entries resulted in 32 CGM graphs with "use clinical judgment" warnings. Eighty-three percent of missed SMBG entries were from 18 participants 55-77 years old. Missing correlation coefficients resulted from glucose concentrations varying <100 mg/dL. A majority of participants (n = 19) were willing to wear CGM again despite reporting minor discomfort at sensor site and with wearing the monitor. CONCLUSIONS: CGM data provided several teaching opportunities in non-insulin-using adults with T2DM. Overall, CGM was acceptable and feasible. Some identified problems may be eliminated by newer technology. FAU - Allen, Nancy A AU - Allen NA AD - Yale University, New Haven, Connecticut, USA. nancy.a.allen@yale.edu FAU - Fain, James A AU - Fain JA FAU - Braun, Barry AU - Braun B FAU - Chipkin, Stuart R AU - Chipkin SR LA - eng GR - F31 NR008818-01A1/NR/NINR NIH HHS/United States GR - T32NR008346-05/NR/NINR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - Diabetes Technol Ther JT - Diabetes technology & therapeutics JID - 100889084 RN - 0 (Glycated Hemoglobin A) SB - IM MH - Adult MH - Aged MH - Blood Glucose Self-Monitoring/methods MH - Body Mass Index MH - Counseling MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 2/*blood/rehabilitation MH - Eating MH - Educational Status MH - Exercise MH - Feasibility Studies MH - Female MH - Glycated Hemoglobin/analysis MH - Humans MH - Infections/epidemiology MH - Male MH - Middle Aged MH - Monitoring, Ambulatory/adverse effects/*methods MH - Pain/etiology MH - Patient Education as Topic PMC - PMC2939842 EDAT- 2009/02/17 09:00 MHDA- 2009/07/30 09:00 PMCR- 2010/03/01 CRDT- 2009/02/17 09:00 PHST- 2009/02/17 09:00 [entrez] PHST- 2009/02/17 09:00 [pubmed] PHST- 2009/07/30 09:00 [medline] PHST- 2010/03/01 00:00 [pmc-release] AID - 10.1089/dia.2008.0053 [pii] AID - 10.1089/dia.2008.0053 [doi] PST - ppublish SO - Diabetes Technol Ther. 2009 Mar;11(3):151-8. doi: 10.1089/dia.2008.0053.